Published

Microdosing psilocybin and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Neuropharmacology
Date: 2026-02-15
Source: PubMed
DOI: 10.1016/j.neuropharm.2025.110732
PubMed: 41187880

Authors

Prochazkova L Marschall J van Elk M Rifkin BD Schon NR Fiacchino D Fejer G Kuchar M Hommel B

Watch author

Derived topics and classifications

psilocybin Microdosing Creativity Other

Citation graph

0 referenced DOIs found in stored source metadata. 2 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development2026-07-03 Microdosing psilocybin and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials.2026-02-15

Related papers

Microdosing psychedelics and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trialsPsyArXiv · 2021-06-14 Microdosing psychedelics and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trialsPsyArXiv · 2021-06-14 Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study.Translational psychiatry · 2022-08-02 Double-blind Placebo-controlled Naturalistic Study of Microdosing With Psilocybin: Effects on Brain Activity, Behavior, Cognition, Creativity, and Mental HealthClinicalTrials.gov · 2021-12-16